DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
86. 肺動脈性肺高血圧症
Pulmonary arterial hypertension
Clinical trials
/
Disease details
臨床試験数
:
1,205
/
薬物数
:
684
- (
DrugBank
:
124
) /
標的遺伝子数
:
100
-
標的パスウェイ数
:
193
Search
2 trials found
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2015-000709-38-AT
(
EUCTR
)
20/10/2015
28/07/2015
Effects of the drug Benzbromaron on the pulmonary vessels
Acute Effects of Benzbromaron on the pulmonary circulation
Pulmonary arterial hypertension
MedDRA version: 18.1;Level: PT;Classification code 10064911;Term: Pulmonary arterial hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Pulmonary arterial hypertension
MedDRA version: 18.1;Level: PT;Classification code 10064911;Term: Pu ...
Trade Name:
Benzbromaron
AL
Product Name:
Benzbromaron
INN or Proposed INN:
BENZBROMARONE
Medical University of Graz
NULL
Not Recruiting
Female: yes
Male: yes
Phase 2
Austria
2
NCT02790450
(
ClinicalTrials.gov
)
October 2015
30/5/2016
Acute Effects of Benzbromaron on the Pulmonary Circulation
Acute Effects of Benzbromaron on the Pulmonary Circulation
Idiopathic Pulmonary Arterial Hypertension
Drug:
Benzbromarone
Medical University of Graz
Ludwig Boltzmann Institute for Lung Vascular Research
Completed
18 Years
90 Years
Both
10
Phase 2
Austria